Cardlytics Q1 revenue $64.3M (-5% YoY); non-GAAP net loss narrows; CFO implies succession

Cardlytics, Inc.

2023-Q1 EPS reported $0.40 revenue$64,331,000

Revenue $64.3M (-5% YoY); GAAP net income $13.6M ($0.40 diluted) vs $33.0M ($0.91) last year.
Non-GAAP net loss $(9.2M) ($0.25) vs $(14.2M) ($0.38); Adjusted EBITDA loss $(6.1M) improved from $(10.5M).
Cardlytics MAUs 188.8M (+6% YoY); ARPU $0.34; Bridg ARR $21.8M.
Q2 guidance: Billings $98-109M, Revenue $65-74M, Adjusted EBITDA loss $(10)-$(6)M.
CFO Andy Christiansen implies succession in earnings release; no replacement announced yet.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Cardlytics, Inc. reported first quarter ended March 31, 2023 results: revenue $64.3 million, net income $13.6 million, EPS $0.40 per diluted share.

Period: first quarter ended March 31, 2023
Revenue: $64.3 million
Net income: $13.6 million
EPS: $0.40 per diluted share
Result: reported results

Exact text from the filing

for a bright future, and our cost-discipline and responsible investments will allow my successor to hit the ground running." First Quarter 2023 Financial Results • Revenue was $64.3 million, a decrease of (5)% year-over-year, compared to $67.9 million in the first quarter of 2022. • Billings, a non-GAAP metric, was $95.6 million, a decrease of (3)% year-over-year,

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Cardlytics, Inc. filing history →

Source: SEC EDGAR

accession 0001666071-23-000071

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.